Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015

dc.contributor.authorAnsari, Uzma
dc.contributor.authorLawsin, Adrian
dc.contributor.authorCampbell, Davina
dc.contributor.authorAlbrecht, Valerie
dc.contributor.authorWilson, Lucy E
dc.contributor.authoret al
dc.date.accessioned2023-08-03T21:37:26Z
dc.date.available2023-08-03T21:37:26Z
dc.date.issued2017-10-04
dc.descriptionAuthors: - Uzma Ansari, Adrian Lawsin, Davina Campbell, Valerie Albrecht, Gillian McAllister, Sandra Bulens, Maroya Spalding Walters, Jesse T Jacob, Sarah W Satola, Lucy E Wilson, Ruth Lynfield, Paula M Snippes Vagnone, Sarah J Janelle, Karen Xavier, Ghinwa Dumyati, Dwight Hardy, Erin C Phipps, Karissa Culbreath, Zintars Beldavs, Karim Morey, Marion A Kainer, Sheri Roberts, Alexander Kallen, J Kamile Rasheed, Maria S Karlssonen_US
dc.description.abstractBackground Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as an important cause of healthcare-associated infections. We characterized the molecular epidemiology of CRE in isolates collected through the Emerging Infections Program (EIP) at the Centers for Disease Control and Prevention (CDC). Methods From 2011–2015, 8 U.S. EIP sites (CO, GA, MD, MN, NY, NM, TN and OR) collected CRE (Escherichia coli, Enterobacter aerogenes, Enterobacter cloacae complex, Klebsiella pneumoniae, and Klebsiella oxytoca) isolated from a normally sterile site or urine. Isolates were sent to CDC for reference antimicrobial susceptibility testing and real-time PCR detection of carbapenemase genes (blaKPC, blaNDM, blaOXA-48). Phenotypically confirmed CRE were analyzed by whole genome sequencing (WGS) using an Illumina MiSeq benchtop sequencer. Results Among 639 Enterobacteriaceae evaluated, 414 (65%) were phenotypically confirmed as CRE using CDC’s current surveillance definition (resistant to ertapenem, imipenem, doripenem, or meropenem). Among isolates confirmed as CRE, 303 (73%) were carbapenemase-producers (CP-CRE). The majority of CP-CRE originated from GA (39%), MD (35%) and MN (11%); most non-CP-CREs originated from MN (27%), CO (25%) and OR (17%). K. pneumoniae was the predominant carbapenemase-producing species (78%) followed by E. cloacae complex spp (12%), E. coli (7.9%), E. Aerogenes (0.9%) and K. oxytoca (0.6%). The most common carbapenemase genes detected were blaKPC-3 (76%) and blaKPC-2 (19%); blaNDM and blaOXA-48-like genes were detected in 1.6% and 0.3% of isolates, respectively. For carbapenemase-producing K. pneumoniae, Enterobacter spp, and E. coli, the predominant sequence types (ST) were ST258 (65%), ST171 (35%) and ST131 (29%), respectively. Conclusion The distribution of CP and non-CP-CRE varied across the catchment sites. Among CP-CRE, KPC-producing K. pneumoniae predominated; other carbapenemases were rarely identified in the locations under surveillance. Strain types known to have increased epidemic potential (ST258 and ST131) were common among carbapenemase-producing K. pneumoniae and E. coli isolates, respectively. Disclosures All authors: No reported disclosures.en_US
dc.description.urihttps://academic.oup.com/ofid/article/4/suppl_1/S179/4294266en_US
dc.format.extent1 pageen_US
dc.genrejournal articlesen_US
dc.identifierdoi:10.13016/m2byt9-5wai
dc.identifier.citationUzma Ansari, MS and others, Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015, Open Forum Infectious Diseases, Volume 4, Issue suppl_1, Fall 2017, Page S179, https://doi.org/10.1093/ofid/ofx163.328en_US
dc.identifier.urihttps://doi.org/10.1093/ofid/ofx163.328
dc.identifier.urihttp://hdl.handle.net/11603/29060
dc.language.isoen_USen_US
dc.publisherOxford University Pressen_US
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Emergency Health Services Department Collection
dc.relation.ispartofA. All Hilltop Institute (UMBC) Works
dc.relation.ispartofUMBC School of Public Policy
dc.rightsThis work was written as part of one of the author's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law.en_US
dc.rightsPublic Domain Mark 1.0*
dc.rights.urihttp://creativecommons.org/publicdomain/mark/1.0/*
dc.titleMolecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015en_US
dc.typeTexten_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ofx163.328.pdf
Size:
233.59 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.56 KB
Format:
Item-specific license agreed upon to submission
Description: